PATENT CLAIM ANALYSIS

Application Number: 15886640
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-08
Patent Classification: ["424", "094400"]

Abstract:
Disclosed herein are methods and compositions useful in the treatment and/or prevention of a disease or indication associated with accumulation of a bisretinoid, for example A2E. In many embodiments, the disclosed methods and compositions are useful in treating an eye disease, for example macular degeneration.

Claim (Index 13):
The method of  claim 12 , wherein the interfering compound disrupts binding of SapB to A2E.

Metadata:
- Claim Count in Document: 36.0
- Percentile: 88.0
- Lexical Diversity: 1.42857
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14398342', '13988754', '13980687', '12733631', '15118486']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7097914765193574
- 35 USC 102 Novelty (BERT): 0.5339344631020293
- Combined Prediction Score: 0.6922057751776246
- Mean Citation Score: 266.98319000000004
- Max Citation Score: 295.7015
- Similarity Product: 149.84433443409202

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test